18 March 2021

Information on vaccination against COVID-19 infection

For reference: Coronavirus infection COVID-19 is an acute respiratory viral infection, the complications may include viral pneumonia leading to life-threatening inflammatory lung disease or respiratory failure with the risk of death.

The transmission of infection from one person to another occurs through airborne droplets when sneezing or coughing. Contact-household transmission is also possible.

The main symptoms of the disease are an increased body temperature (usually 38-39°C), cough (dry or with a small amount of sputum), a feeling of tightness in the chest, shortness of breath, muscle pain and headache. The disease can also begin with the appearance of loose stools, nausea, vomiting, loss of appetite.

Epidemiological situation on the incidence of coronavirus infections COVID-19 (causative agent – the SARS-CoV-2 virus) in the world (as on 15.03.2021)

As on:

China (PRC)

In the world

Registered cases

Lethal cases

Registered cases

Lethal cases

01.02.2020

11821

259

11947

259

01.03.2020

79968

2873

86982

2978

01.04.2020

82617

3315

857442

42210

01.05.2020

84385

4643

3305068

233984

01.06.2020

84588

4645

6211927

373744

01.07.2020

85232

4648

10466465

513729

06.07.2020

85320

4648

11442109

536677

13.07.2020

85568

4648

12903885

571460

20.07.2020

86068

4653

14490068

605952

27.07.2020

87028

4659

16208873

648415

24.08.2020

90182

4718

23349425

807541

14.09.2020

90695

4741

28892571

922440

21.09.2020

90876

4744

30914336

959088

26.10.2020

91701

4746

42991911

1153041

02.11.2020

91955

4746

46423555

1198893

09.11.2020

92242

4748

50307828

1255005

16.11.2020

92453

4749

54423467

1318094

23.11.2020

92734

4749

58555563

1386917

30.11.2020

93448

4750

62642216

1458079

07.12.2020

94294

4753

66983762

1491660

04.01.2021

96973

4791

85096666

1784920

11.01.2021

97653

4799

90256056

1873398

18.01.2021

98795

4804

95033122

1965818

25.01.2021

100137

4811

99194760

2060621

01.02.2021

100975

4825

102957194

2237790

08.02.2021

101317

4831

106153244

2240959

15.02.2021

101537

4838

108810860

2320309

22.02.2021

101701

4842

111361041

2383601

01.03.2021

101921

4844

114067605

2445444

09.03.2021

102126

4848

117150480

2511549

15.03.2021

102364

4849

119863507

2562346

The number of cases in the world (as on 15.03.2021)

Region

Date of the first case

Country

Cases

Morbidity per 100 thousand

Lethal outcomes

Lethal outcomes per 100 thousand

Western Pacific

1.    

01.12.2019

China

102364

7,3

4849

0,34

2.    

14.01.2020

Japan

447284

355,1

8587

6,82

 

 

Cruise ship «Diamond Princess»

712

 

13

 

3.    

19.01.2020

The Republic of Korea

96017

185,4

1675

3,23

4.    

23.01.2020

Vietnam

2554

2,7

35

0,04

5.    

24.01.2020

Singapore

60105

1053,8

30

0,53

6.    

25.01.2020

Australia

29126

112,3

909

3,5

7.    

25.01.2020

Malaysia

323763

979,1

1210

3,66

8.    

27.01.2020

Cambodia

1325

8,7

1

0,01

9.    

30.01.2020

Philippines

621498

567,4

12829

11,71

10.    

28.02.2020

New Zealand

2430

48,6

26

0,52

11.    

09.03.2020

Mongolia

4083

121,5

4

0,12

12.    

10.03.2020

Brunei

199

46

3

0,69

13.    

19.03.2020

Fiji

66

7,4

2

0,22

14.    

21.03.2020

Papua New Guinea

2173

24,8

21

0,24

15.    

24.03.2020

Laos

48

0,7

0

0

16.    

03.10.2020

Solomon islands

18

2,7

0

0

17.    

29.10.2020

Marshall Islands

4

7,5

0

0

18.    

11.11.2020

Vanuatu

3

1

0

0

19.    

18.11.2020

Samoa

3

1,5

0

0

20.    

08.01.2021

Micronesia

1

0,9

0

0

Southeast Asia

21.    

12.01.2020

Thailand

26927

40,4

86

0,13

22.    

24.01.2020

Nepal

275231

962

3014

10,54

23.    

27.01.2020

Sri Lanka

87907

403,2

527

2,42

24.    

30.01.2020

India

11359048

821,6

158607

11,47

25.    

02.03.2020

Indonesia

1419455

531,8

38426

14,4

26.    

06.03.2020

Butane

868

113,8

1

0,13

27.    

07.03.2020

Maldives

21572

5365,2

64

15,92

28.    

08.03.2020

Bangladesh

557395

324,3

8545

4,97

29.    

21.03.2020

East Timor

196

16,2

0

0

30.    

23.03.2020

Myanmar

142147

263

3202

5,92

European

31.    

25.01.2020

France

4131874

6000,4

90583

131,55

32.    

28.01.2020

Germany

2578835

3101,5

73959

88,95

33.    

29.01.2020

Finland

66869

1209,9

786

14,22

34.    

30.01.2020

Italy

3223142

5352,4

102145

169,62

35.    

31.01.2020

Great Britain

4271710

6409,4

125753

188,68

36.    

31.01.2020

Spain*

3183704

6783,3

72258

153,95

37.    

31.01.2020

Sweden*

712527

6908,7

13146

127,46

38.    

04.02.2020

Belgium

805321

7017,3

22421

195,37

39.    

21.02.2020

Israel

818548

8959,6

6008

65,76

40.    

25.02.2020

Austria

493568

5536,1

8873

99,52

41.    

25.02.2020

Croatia

251045

6158,7

5677

139,27

42.    

25.02.2020

Switzerland*

570645

6658,5

10112

117,99

43.    

26.02.2020

North Macedonia

112646

5423,2

3319

159,79

44.    

26.02.2020

Georgia

274989

7385,2

3648

97,97

45.    

26.02.2020

Norway

80440

1449,2

639

11,51

46.    

26.02.2020

Greece

221147

2058,9

7091

66,02

47.    

26.02.2020

Romania

859709

4431,1

21483

110,73

48.    

27.02.2020

Denmark

221151

3838

2392

41,51

49.    

27.02.2020

Estonia

84807

6384,3

719

54,13

50.    

27.02.2020

Netherlands

1172975

6696,4

16200

92,48

51.    

27.02.2020

San Marino

4126

11928,3

77

222,61

52.    

28.02.2020

Lithuania

205385

7360,2

3396

121,7

53.    

28.02.2020

Belarus

302323

3213,3

2095

22,27

54.    

28.02.2020

Azerbaijan

240295

2407,4

3282

32,88

55.    

28.02.2020

Monaco

2107

5501,3

27

70,5

56.    

28.02.2020

Iceland

6072

1700,9

29

8,12

57.    

29.02.2020

Luxembourg

57877

9427,8

689

112,23

58.    

29.02.2020

Ireland

226741

4607,2

4534

92,13

59.    

01.03.2020

Armenia

178385

6022,2

3255

109,89

60.    

01.03.2020

Czech Republic

1399078

13082,9

23226

217,19

61.    

02.03.2020

Andorra

11266

14789,2

113

148,34

62.    

02.03.2020

Portugal

814257

7923,4

16684

162,35

63.    

02.03.2020

Latvia

93781

4914,9

1767

92,61

64.    

03.03.2020

Ukraine

1460756

3519,8

28303

68,2

65.    

03.03.2020

Liechtenstein

2612

6806

55

143,31

66.    

04.03.2020

Hungary

516490

5286,7

16952

173,52

67.    

04.03.2020

Poland

1906632

4976,5

47178

123,14

68.    

04.03.2020

Slovenia

200374

9473,3

3934

185,99

69.    

05.03.2020

Bosnia and Herzegovina

142160

4048,6

5446

155,1

70.    

06.03.2020

Vatican

27

4462,8

0

0

71.    

06.03.2020

Serbia

592347

6285,5

6407

67,99

72.    

06.03.2020

Slovakia

337503

6193,7

8528

156,5

73.    

07.03.2020

Malta

26535

5376,3

351

71,12

74.    

07.03.2020

Bulgaria

278557

4007,2

11285

162,34

75.    

07.03.2020

Moldavia

204463

5765,2

4330

122,09

76.    

08.03.2020

Albania

117474

4127,8

2045

71,86

77.    

10.03.2020

Turkey

2879390

3462,7

29489

35,46

78.    

10.03.2020

Cyprus

39651

4526,9

240

27,4

79.    

13.03.2020

Kazakhstan

274532

1455,5

3193

16,93

80.    

15.03.2020

Uzbekistan

80567

232,5

622

1,79

81.    

17.03.2020

Montenegro

83693

13450,8

1129

181,45

82.    

18.03.2020

Kyrgyzstan

86850

1331,3

1481

22,7

83.    

07.04.2020

Abkhazia

13072

5367

204

83,76

84.    

30.04.2020

Tajikistan

13308

145,8

90

0,99

85.    

06.05.2020

South Ossetia

3135

5856,3

70

130,76

American

86.    

21.01.2020

USA

29437706

8921,7

534877

162,1

87.    

26.01.2020

Canada

914595

2379

22455

58,41

88.    

26.02.2020

Brazil

11483370

5403,7

278229

130,93

89.    

28.02.2020

Mexico

2166290

1695,2

194710

152,36

90.    

29.02.2020

Ecuador

302221

1715,5

16236

92,16

91.    

01.03.2020

Dominican Republic

246045

2291,1

3222

30

92.    

03.03.2020

Argentina

2195722

4886

53670

119,43

93.    

03.03.2020

Chile

891110

4497,6

21674

109,39

94.    

06.03.2020

Colombia

2303144

4772,5

61143

126,7

95.    

06.03.2020

Peru

1412406

4391,5

49003

152,36

96.    

06.03.2020

Costa Rica

209093

4221,4

2862

57,78

97.    

07.03.2020

Paraguay

180014

2516,7

3476

48,6

98.    

09.03.2020

Panama

347919

9242,9

5994

159,24

99.    

10.03.2020

Bolivia

259389

2261,5

11958

104,26

100.   

10.03.2020

Jamaica

30499

1118,5

485

17,79

101.   

11.03.2020

Honduras

178277

1946,6

4334

47,32

102.   

11.03.2020

Saint Vincent and the Grenadines

1680

1513,5

9

8,11

103.   

12.03.2020

Guyana

9160

1142,7

207

25,82

104.   

12.03.2020

Cuba

61472

542,4

370

3,26

105.   

13.03.2020

Venezuela

145379

442

1430

4,35

106.   

13.03.2020

Trinidad and Tobago

7783

557,9

140

10,04

107.   

13.03.2020

Saint Lucia

4031

2202,7

51

27,87

108.   

13.03.2020

Antigua and Barbuda

963

992,8

27

27,84

109.   

14.03.2020

Suriname

9024

1553,2

176

30,29

110.   

14.03.2020

Guatemala

182881

1034,4

6568

37,15

111.   

14.03.2020

Uruguay

71691

2098,8

712

20,84

112.   

16.03.2020

Bahamas

8658

2225,7

185

47,56

113.   

17.03.2020

Barbados

3421

1192

37

12,89

114.   

18.03.2020

Nicaragua

6537

105,5

175

2,82

115.   

19.03.2020

Haiti

12664

116,1

250

2,29

116.   

18.03.2020

Salvador

62086

962

1950

30,21

117.   

23.03.2020

Grenada

148

132,1

1

0,89

118.   

23.03.2020

Dominica

156

216,7

0

0

119.   

23.03.2020

Belize

12370

3189,1

316

81,47

120.   

25.03.2020

Saint Kitts and Nevis

43

76,5

0

0

Eastern Mediterranean

121.   

30.01.2020

UAE

426397

4363,9

1395

14,28

122.   

14.02.2020

Egypt

190924

188,2

11300

11,14

123.   

19.02.2020

Iran

1746953

2060,5

61230

72,22

124.   

21.02.2020

Lebanon

418448

6103,4

5380

78,47

125.   

23.02.2020

Kuwait

209523

4980,3

1172

27,86

126.   

24.02.2020

Bahrain

131001

9027,1

484

33,35

127.   

24.02.2020

Oman

146867

3592

1608

39,33

128.   

24.02.2020

Afghanistan

55972

173,7

2459

7,63

129.   

24.02.2020

Iraq

758184

1928,7

13751

34,98

130.   

26.02.2020

Pakistan

607453

276,2

13537

6,16

131.   

29.02.2020

Qatar

170252

6184,1

266

9,66

132.   

02.03.2020

Jordan

477053

4439,4

5346

49,75

133.   

02.03.2020

Tunisia

241834

2063,1

8389

71,57

134.   

02.03.2020

Saudi Arabia

382407

1117,6

6567

19,19

135.   

02.03.2020

Morocco

488937

1351,5

8723

24,11

136.   

05.03.2020

Palestine

209304

4345,6

2268

47,09

137.   

13.03.2020

Sudan

28984

67,1

1940

4,49

138.   

16.03.2020

Somalia

9190

59,5

367

2,38

139.   

18.03.2020

Djibouti

6268

643,5

63

6,47

140.   

22.03.2020

Syria

16478

96,5

1099

6,44

141.   

24.03.2020

Libya

144993

2139,5

2386

35,21

142.   

10.04.2020

Yemen

2836

9,7

689

2,36

African

143.   

25.02.2020

Nigeria

160657

76,4

2013

0,96

144.   

27.02.2020

Senegal

36892

191,6

963

5

145.   

02.03.2020

Cameroon

40622

166,8

601

2,47

146.   

05.03.2020

Burkina Faso

12372

59,3

144

0,69

147.   

06.03.2020

RSA

1529420

2782,9

51326

93,39

148.   

06.03.2020

Ivory Coast

37653

146,4

211

0,82

149.   

10.03.2020

DR Congo

27014

26,5

717

0,7

150.   

10.03.2020

Togo

8070

99,9

95

1,18

151.   

11.03.2020

Kenya

113236

238,1

1913

4,02

152.   

13.03.2020

Algeria

115265

267,7

3036

7,05

153.   

13.03.2020

Ghana

87762

288,5

685

2,25

154.   

13.03.2020

Gabon

16660

766,7

96

4,42

155.   

13.03.2020

Ethiopia

175467

156,6

2550

2,28

156.   

13.03.2020

Guinea Republic

17742

138,9

102

0,8

157.   

14.03.2020

Mauritania

17438

480,2

444

12,23

158.   

14.03.2020

Eswatini

17237

1501,5

661

57,58

159.   

14.03.2020

Rwanda

20186

168,9

280

2,34

160.   

14.03.2020

Namibia

41200

1651,3

458

18,36

161.   

14.03.2020

Seychelles

3315

3382,7

16

16,33

162.   

14.03.2020

Equatorial Guinea

6562

483,9

98

7,23

163.   

14.03.2020

Republic of the Congo

9329

173,4

131

2,43

164.   

16.03.2020

Benin

6501

63

81

0,79

165.   

16.03.2020

Liberia

2030

41,1

85

1,72

166.   

16.03.2020

Tanzania

509

0,9

21

0,04

167.   

14.03.2020

CAR

5023

105,9

63

1,33

168.   

18.03.2020

Mauritius

742

58,8

10

0,79

169.   

18.03.2020

Zambia

84797

474,8

1158

6,48

170.   

17.03.2020

Gambia

4985

212,3

153

6,52

171.   

19.03.2020

Niger

4860

21,8

182

0,82

172.   

19.03.2020

Chad

4309

27

154

0,97

173.   

20.03.2020

Cape Verde

16101

2927,5

156

28,36

174.   

21.03.2020

Zimbabwe

36484

249,1

1503

10,26

175.   

21.03.2020

Madagascar

21356

83,2

326

1,27

176.   

21.03.2020

Angola

21380

67,2

521

1,64

177.   

22.03.2020

Uganda

40581

101,4

334

0,83

178.   

22.03.2020

Mozambique

64516

212,5

725

2,39

179.   

22.03.2020

Eritrea

3038

86,9

7

0,2

180.   

25.03.2020

Mali

8913

45,3

360

1,83

181.   

25.03.2020

Guinea-Bissau

3447

179,4

52

2,71

182.   

30.03.2020

Botswana

34098

1479,9

424

18,4

183.   

31.03.2020

Sierra Leone

3937

50,4

79

1,01

184.   

01.04.2020

Burundi

2461

21,9

3

0,03

185.   

02.04.2020

Malawi

32789

186,7

1082

6,16

186.   

05.04.2020

South Sudan

9490

85,8

104

0,94

187.   

06.04.2020

West Sahara

10

1,7

1

0,17

188.   

06.04.2020

Sao Tome and Principe

2078

966,5

32

14,88

189.   

01.05.2020

Comoros

3635

450,9

146

18,11

190.   

13.05.2020

Lesotho

10530

524,6

309

15,39

In February 2021, the National Action Plan for Vaccination against COVID-19 Infection in the Republic of Belarus for 2021-2022 was approved.

This plan defines the tactics of vaccination against COVID-19 infection with the gradual inclusion of specific contingents in the vaccination campaign in accordance with the following stages:

Stage 1. Medical and pharmaceutical workers (including students of medical educational institutions involved in providing medical care to the population). Workers of educational institutions. Persons over 18 years old living in institutions with a round-the-clock stay (if they can be vaccinated according to the instructions for vaccines) – February–March 2021.

Stage 2. Persons aged 61 and over, persons with chronic diseases, other persons at risk of a severe course of the disease – as vaccines become available.

Stage 3. Persons with a higher risk of contracting COVID-19 infection compared to the rest of the population due to their professional activities (workers of trade, catering, consumer services, transport, cultural institutions, sports facilities, etc.), workers of government agencies who ensure the security of the state and the vital activity of the population, workers of diplomatic missions and members of their families, others – as vaccines become available.

Stage 4. The rest of the population (taking into account the provision of vaccination coverage of at least 60 percent of the population) – during 2021.

The Ministry of Health of the Republic of Belarus is developing a platform for online registration for vaccination against COVID-19 infection with the possibility of its subsequent integration into the e-health system of the Republic of Belarus.                                                             

The Gam-COVID-Vac "Sputnik V" vaccine is approved by the Ministry of Health of Belarus for use in people over 60 years old.

For today, there is no vaccine for the prevention of SARS-CoV-2 infection registered in the Republic of Belarus for use in patients over 60 years old. Therefore, registration of the drug for  this age group is extremely relevant for the country's healthcare system.

The developer of the vaccine FSBI "The National Research Center for Epidemiology and Microbiology named after N.Gamaleya" of the Ministry of Health of Russia, Russian Federation, made the necessary changes and additions to the instructions for use in order to expand the age limits for the use of the drug for the prevention of coronavirus infection.

Preparations for mass vaccination of the population have begun in Belarusian healthcare institutions, the specialized training sessions are being held. Older people will be asked to undergo a comprehensive medical examination in compliance with the necessary anti-epidemic measures in preparation for vaccination.

Dzmitryj Hryńko, director of the RUE "Center for Expertise and Testing in Healthcare" of the Ministry of Health of the Republic of Belarus:

"Combined vector vaccine for the prevention of coronavirus infection "Sputnik V" is developed by FSBI "The National Research Center for Epidemiology and Microbiology named after N.Gamaleya" of the Ministry of Health of Russia and approved by the Ministry of Health of the Republic of Belarus for use in people over 60 years old. This conclusion was made based on the results of the registration dossier materials assessment made by the specialists of our center and leading scientific experts – infectious disease specialists, epidemiologists, geneticists of Belarus. The decision was made based on the permission to use the vaccine in people over 60 years old, adopted in December 2020 by the regulator of the producing country – the Ministry of Health of Russia."

Clinical studies that investigated the efficiency and safety of the "Sputnik V" vaccine in the elderly.

Vaccines Gam-COVID-Vac "Sputnik V" in persons over 60 years old were studied in Russia in two clinical studies.

One study involved volunteers aged 18 or older. Almost 40 thousand people took part in this study. The number of volunteers among them that are over 60 years old and received the Sputnik V vaccine amounted to 1 thousand 029 people, 588 of volunteers over 60 are men and 441 participants are women. The oldest participant of the study was 87 years old.

110 volunteers took part in the second study of the vaccine that was used only in people over 60 years old. The name of this study is "The open study of the safety, tolerability and immunogenicity of the medical product "Gam-COVID-Vac", the solution for intramuscular administration with the participation of volunteers in the age group over 60 years old."

So, today there is documented data on the efficiency and safety of the "Sputnik V" vaccine obtained from more than 1000 volunteers over 60 years old which served as a sufficient basis for amending the instructions for medical use.

About the results obtained in the course of "The open study of the safety, tolerability and immunogenicity of the medical product "Sputnik" in volunteers of the age group over 60 years old".

The obtained  data demonstrated that the vaccine administration induces the formation of an intense immune response to the SARS-CoV-2 virus. The vaccine helps to involve in the process both the humoral immune response – specific blood proteins-antibodies that can prevent the development of covid infection – and the cellular link of immunity – blood cells that provide antiviral protection.

The humoral immune response is provided by specific blood proteins – antibodies that can prevent the development of covid infection. Specific antibodies are formed in response to the introduction of the vaccine in almost 100% of the vaccinated people (this is called seroconversion). The maximum level of titer-specific antibodies in time is observed on the 42nd day after vaccination.

The cellular link of immunity is blood cells that provide protection against viral and bacterial infections. Double immunization of volunteers with the drug "Gam-COVID-Vac" forms the both CD4 + and CD8+ antigen-specific T-lymphocytes on the 28th day after the introduction of the first component of the vaccine (T-lymphocytes are cells that provide antiviral protection). The obtained indicators show a pronounced formation of the cellular link in immunity of volunteers of the age group over 60 years after immunization with the drug "Gam-COVID-Vac".

Studies of the immunogenicity, efficiency and safety of the drug in volunteers aged 60 years and older are ongoing.

In addition to the main report on a separate study, the results of evaluating the safety and efficiency in a group of patients over 60 years old were supplemented with data from the interim report on the clinical study “Randomized double-blind placebo-controlled multicenter clinical study of the efficiency, immunogenicity and safety of the combined vector vaccine Gam-COVID-Vac ("Sputnik V") in parallel groups in the prevention of coronavirus infection caused by the SARS-CoV-2 virus".

Thus, the conducted clinical studies allow us to make the next conclusions about Gam-COVID-Vac vaccine ("Sputnik V"):

  1. it is effective in a group of patients over 60 years old.

  2. it has a favorable safety profile.

  3. the safety profile in this group does not differ from the general population of patients.

  4. no unexpected serious adverse events were identified.

  5. adverse events noted in the course of studies are generally characteristic of vaccine preparations.

Efficiency of vaccination with one or two components of the Gam-COVID-Vac ("Sputnik V") vaccine.

The single immunization with component I or II of the drug "Gam-COVID-Vac" and double immunization in the "prime-boost" mode with the drug "Gam-COVID-Vac" can lead to the formation of antigen-specific IgG antibodies in 100% of volunteers on 21st day after immunization. The maximum antibody titers with double immunization in the "prime-boost" mode with the drug "Gam-COVID-Vac" are shown on the 42nd day after the start of immunization. Double immunization in the "prime-boost" mode with the drug "Gam-COVID-Vac" leads to significantly higher titers of antigen-specific IgG antibodies compared with the single immunization with component I or II of the drug "Gam-COVID-Vac". This shows the advantages of the booster vaccination scheme and allows to recommend it for further clinical practice.

How does the acquired specific immunity differ in those who have been ill and vaccinated?

Comparison of the titers of antigen-specific IgG antibodies in vaccinated volunteers on day 28 from the start of vaccination with titers of antigen-specific IgG antibodies in those who recovered after COVID-19 (patients who had mild or moderate disease form one month after complete recovery) showed that with a single administration the titers are comparable, and in case of vaccination in the prime-boost mode the titers in vaccinated volunteers exceed the titers in patients one month after recovery.

The production of a vaccine against COVID-19 was discussed on March 10, 2021 at a meeting with the participation of Prime Minister of Belarus Raman Haloŭčanka.

“The vaccine will be developed – we have no doubts about that. Another question is that the creation of a domestic vaccine has a number of necessary conditions'', said Minister of Health Dzmitryj Pinievič. He explained that we are talking not only about creating a prototype of the vaccine and receiving small batches, but also about industrial production.

“The complex group has been created. The main work is concentrated on the basis of the institutions of the Ministry of Health – in particular, this Republican Scientific and Practical Center. But success is possible in case of joint work with interested colleagues, including colleagues from the Academy of Sciences and universities”, the minister said. ”Quite strict deadlines have been set. It is planned to create a prototype of the vaccine by autumn, and a pilot batch by the end of the year”.

Speaking about the prospects for the appearance of a domestic vaccine, deputy minister, head state sanitary doctor Aliaksandr Tarasienka noted that there are all opportunities for this. The RSPC has experience in creating vaccines – in particular, against rabies. The equipment available in the center makes it possible to implement the first stages of work. Moreover, a list of the necessary high-tech equipment which is planned for purchase has been formed.

As the director of the Republican Scientific and Practical Center, candidate of medical sciences, associate professor Uladzimir Harbunoŭ said, “The Republican Scientific and Practical Center for Epidemiology and Microbiology makes 300-600 studies on COVID-19 daily. The center has developed two drugs for diagnosing coronavirus infection – the PCR kit and the ELISA kit (for detecting antibodies in the blood serum of patients), which complement each other and are used at different stages. We use them successfully and implement them in practical healthcare. In addition, domestic developments are used by five laboratories, which are both engaged in scientific research and carry out research in the interests of individuals and legal entities, including travel companies and other organizations". 

Uladzimir Harbunoŭ noted: the center's specialists are studying post-vaccination and post-infectious immunity. “That is, we are looking at how effective the vaccine used in our country is, and we are also studying immunity after a disease. Our data can form the basis for the development of new vaccine preparations and the choice of the optimal vaccination for the available range of vaccines. We will soon find out how long immunity lasts after illness and after vaccination”, he said.

The Republican Scientific and Practical Center for Epidemiology and Microbiology is a leading institution in Belarus in the field of scientific developments in virology, microbiology, epidemiology, parasitology, immunology and a number of other disciplines. Here they carry out scientific research of a fundamental, but mainly applied nature. Most of the developments are completed with the production of diagnostic kits and methods that are introduced into practice and used in the country. The center has 11 laboratories, nine of which deal with virology.

In accordance with the order of the Ministry of Health of the Republic of Belarus of December 31, 2020 No. 1412 "On Vaccination Against COVID-19 Infection", medical workers are being vaccinated.

2,285 medical workers were vaccinated during the first stage of the vaccination campaign against COVID-19 infection in Minsk with the Gam-COVID-Vak vaccine (manufactured in the Russian Federation), including pharmaceutical workers and students of medical institutions involved in providing medical care to the population.

As a result of the organizational work implemented in outpatient healthcare institutions, lists of workers of education, social service institutions and persons living in institutions with a round-the-clock stay that are need to be vaccinated against COVID-19 infection were compiled.

The vaccination procedure consists of 2 injections with an interval of 3 weeks, which will form a complete protection against the disease.

The conditions for storing vaccines in healthcare institutions in Minsk have been created, additional medical freezing equipment has been purchased.

 

The information was prepared on the basis of electronic messages published on the websites of the Ministry of Health of the Republic of Belarus, the State Institution "Minsk City Center for Hygiene and Epidemiology", the State Institution "Republican Scientific and Practical Center for Epidemiology and Microbiology".